GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection.
| Website: | www.glycomimetics.com |
| Email: | info@glycomimetics.com. |
| Main Phone: | +1 240 243-1201 |
| Address: | 9708 Medical Center Drive |
| Address 2: | Suite 1700 |
| State: | MD |
| City / Town: | Rockville |
| Country: | USA |
| Postal Code: | 20850 |
| Exchange: | NSD |
| CEO: | Rachel K. King |
| Employees: | 50 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
Gathering Data... Please wait GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection.
| Website: | www.glycomimetics.com |
| Email: | info@glycomimetics.com. |
| Main Phone: | +1 240 243-1201 |
| Address: | 9708 Medical Center Drive |
| Address 2: | Suite 1700 |
| State: | MD |
| City / Town: | Rockville |
| Country: | USA |
| Postal Code: | 20850 |
| Exchange: | NSD |
| CEO: | Rachel K. King |
| Employees: | 50 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
| Last Price 13.44 | Change $ 0.12 | Change % 0.90 | Tick N/A |
| Bid N/A | Bid Size 0.00 | Ask 13.50 | Ask Size 100.00 |
| Open 13.42 | High 13.47 | Low 12.71 | Prev Close 13.32 |
| Last Trade | Volume 266,004 | 52 Wk Hi 19.20 | 52 Wk Low 8.29 |
| Market Cap 580.2 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 43,168,969.00 | EPS (TTM) -1.19 | PE Ratio N/A | Exchange NSD |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 23 | 25 |
| Number of Buys | 8 | 8 |
| Number of Sells | 15 | 17 |
| Net Activity | -42702 | -46702 |
| Last 10 Buys | Shares |
|---|---|
| Daniel M. Junius | 1,000 |
| Mark A. Goldberg | 1,000 |
| Michael A. Henos | 1,000 |
| Michael A. Henos | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Brian M. Hahn | 1,000 |
| Peter J. Barris | 1,000 |
| Peter J. Barris | 1,000 |
| M. James Barrett | 1,000 |
| Sandell D Scott | 1,000 |
| Sandell D Scott | 1,000 |
| M. James Barrett | 1,000 |
| Helen M. Thackray | 1,000 |
| Helen M. Thackray | 1,000 |
| Helen M. Thackray | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 35 | 35 | 35 | 35 |
| Low Target Price Estimate | 21 | 21 | 21 | 21 |
| Mean Target Price Estimate | 28.25 | 28.25 | 28.25 | 28.25 |
| Standard Deviation | 6.4 | 6.4 | 6.4 | 6.4 |
| Date of Most Recent Estimate | 05/31/18 | 05/03/18 | 05/03/18 | 05/31/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-12 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-24 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-21 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-21 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-21 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-21 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-21 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-21 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2018-05-21 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-11 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1 | 1 |
© 2019 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
